Fig 1.
Exclusion criteria for patients included in the study with follow-up rates.
Table 1.
Baseline characteristics of respondents and non-respondents to 12-month follow-up.
Table 2.
Baseline characteristics of the whole myelopathy group and of the two procedural groups.
Table 3.
Area under the curve and cut-off estimates for Minimal Clinically Important Difference for all Patient-Reported Outcome Measures at 12 months.
Table 4.
Minimal Clinically Important Difference cut-off estimates for all Patient-Reported Outcome Measures in the two procedural subgroups at 12 months.
Fig 2.
Percentage of patients achieving improvement larger than the Minimal Clinically Important Difference (MCID) according to the Neck Disability Index (NDI), Numeric Rating Scale for arm pain (NRS-AP) and neck pain (NRS-NP), Euro-Quol-5D-3L (EQ-5D-3L) and European Myelopathy Score (EMS). Results are provided by the percentage change score from baseline to 12-month follow-up.